• All sections
  • A - Human necessities
  • A61K - Preparations for medical, dental or toiletry purposes
  • A61K 47/60 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol

Patent holdings for IPC class A61K 47/60

Total number of patents in this class: 3830

10-year publication summary

119
225
351
432
391
434
417
403
384
249
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Nektar Therapeutics
438
88
Hanmi Pharm. Co., Ltd.
574
71
The Regents of the University of California
20059
59
Bristol-myers Squibb Company
4867
47
Ascendis Pharma A/S
182
43
The Johns Hopkins University
5709
42
Massachusetts Institute of Technology
10102
40
Ascendis Pharma Growth Disorders A/S
56
39
Board of Regents, The University of Texas System
5849
34
Synthorx, Inc.
78
33
Amgen Inc.
4106
26
Quiapeg Pharmaceuticals AB
45
26
Ascendis Pharma Bone Diseases A/S
47
25
Janssen Pharmaceutica N.V.
3369
24
NOK Corporation
2229
23
The Board of Trustees of the Leland Stanford Junior University
6451
22
Northwestern University
3408
22
Ambrx, Inc.
183
20
Yale University
2401
20
SeaGen Inc
591
20
Other owners 3106